Gloxitel 40 Tablet DT contains Telmisartan 40 mg, an angiotensin II receptor antagonist used primarily for the management of hypertension. By selectively blocking the binding of angiotensin II to the AT1 receptor, Telmisartan promotes vasodilation, thereby reducing peripheral vascular resistance and lowering blood pressure. This mechanism helps prevent complications associated with hypertension, such as stroke, myocardial infarction, and renal impairment. Gloxitel 40 Tablet DT is formulated as a dispersible tablet, facilitating ease of administration, particularly for patients with swallowing difficulties. It is indicated for the treatment of essential hypertension and may be used alone or in combination with other antihypertensive agents to achieve optimal blood pressure control. The medication is generally well-tolerated; however, common adverse effects may include dizziness, headache, and fatigue. It is contraindicated in patients with hypersensitivity to Telmisartan or any tablet components, and caution is advised in patients with renal or hepatic impairment. Regular monitoring of blood pressure, renal function, and electrolytes is recommended during therapy. Gloxitel 40 Tablet DT should be used under medical supervision, adhering to prescribed dosages to maximize therapeutic benefits and minimize potential risks.